- 04/05/2020 - 31/08/2020
- Carlos Chaccour
The COVID-19 pandemic has now spread to almost all countries around the world. The response in almost all countries in Europe has been to implement a series of “non-pharmaceutical interventions” (NPIs) – including a banning of mass gatherings, closure of schools and universities, and more general restrictions on populations movements including full lockdowns. In most countries, we now have evidence to show that these NPIs have significantly reduced transmission such that the reproductive number – the average number of new infections generated by each initial infection – is close to or just below the threshold value of 1 required to bring the epidemic under control (Flaxman et al. 2020). However, there remains considerable uncertainty as to how these measures can be relaxed in the coming weeks and months whilst ensuring there are no rebound epidemics.
One of the proposed methods for relaxing existing interventions is to restrict movements to a smaller subset of the population. Two approaches are possible, alone or in tandem:
- Restrict the movement of those at highest risk from severe disease – essentially shielding this population whilst allowing a degree of ongoing transmission in the lower risk population
- Using app-based technology, combined with rapid testing, to rapidly isolate cases and their contacts.
The detailed data collected by the Catalonian government provide the opportunity to better understand the impact of these two approaches.
Other projectsSee Past Projects
Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo
Combating Bacterial Resistance In Europe
Application to medical devices
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
Prioritising Antimicrobial Resistance: establishing an interdisciplinary International Research Partnership to tackle an evolving global health threat
An interdisciplinary International Research Partnership to tackle an evolving global health threat
Development of new metal-antibiotics against pathogens causing chronic infections in patients with cystic fibrosis.
New metal-antibiotics for patients with cystic fibrosis
Non-invasive ultrasound-based screening for meningitis: Proof-of concept in infants
Improved case detection through TB contact risk stratification by Xpert results and spatial parameters in Mozambique
Evaluation of the effect of weekly high dose rifapentine and isoniazid (3HP) vs periodic 3HP vs 6H for preventing TB among HIV-positive individuals
Search for new target proteins and use of antibacterial or inhibitory peptides against resistance mechanisms in 'Acinetobacter baumannii'
Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique
Integrating and decentralizing diabetes and hypertension services in Africa
Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.
Pilot Study to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission
Cendea de Cizur
Conèixer la propagació. Entendre la protecció
A breakthrough device for the rapid detection of antimicrobial resistance
Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19